tiprankstipranks
Trending News
More News >
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Income Statement

Compare
617 Followers

C4 Therapeutics Income Statement

Last quarter (Q3 2025), C4 Therapeutics's total revenue was $11.23M, a decrease of -26.90% from the same quarter last year. In Q3, C4 Therapeutics's net income was $-32.17M. See C4 Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 35.58M$ 20.76M$ 31.10M$ 45.78M$ 33.20M
Gross Profit
$ 35.58M$ 13.02M$ 31.10M$ 45.78M$ -45.24M
Operating Expenses
$ 155.20M$ 152.05M$ 160.63M$ 127.92M$ 15.20M
Depreciation and Amortization
$ 1.82M$ 7.74M$ 1.68M$ 1.49M$ 1.62M
EBITDA
$ -103.37M$ -122.10M$ -124.28M$ -80.25M$ -58.83M
Operating Income
$ -119.61M$ -139.03M$ -129.53M$ -82.13M$ -60.45M
Other Income/Expenses
$ 14.43M$ 7.82M$ 1.36M$ -1.76M$ -5.26M
Pretax Income
$ -105.19M$ -131.21M$ -128.18M$ -83.89M$ -65.71M
Net Income
$ -105.32M$ -132.49M$ -128.18M$ -83.89M$ -66.33M
Per Share Metrics
Basic EPS
$ -1.52$ -2.67$ -2.62$ -1.82$ -1.54
Diluted EPS
$ -1.52$ -2.67$ -2.62$ -1.82$ -1.54
Weighted Average Shares Outstanding
69.37M 49.64M 48.86M 46.04M 43.06M
Weighted Average Shares Outstanding (Diluted)
69.37M 49.64M 48.86M 46.04M 43.06M
Currency in USD

C4 Therapeutics Earnings and Revenue History